Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(14%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_4
6
86%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
6(85.7%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(6)

Detailed Status

Completed6
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 46 (85.7%)
N/A1 (14.3%)

Trials by Status

active_not_recruiting114%
completed686%

Recent Activity

1 active trials
Showing 5 of 7
active_not_recruitingnot_applicable

Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II

NCT04893291
completedphase_4

Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction

NCT01347554
completedphase_4

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

NCT02151929
completedphase_4

Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome

NCT01857843
completedphase_4

Everolimus Stent in Myocardial Infarction

NCT01684982
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04893291Not Applicable

Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II

Active Not Recruiting
NCT01347554Phase 4

Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction

Completed
NCT02151929Phase 4

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

Completed
NCT01857843Phase 4

Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome

Completed
NCT01684982Phase 4

Everolimus Stent in Myocardial Infarction

Completed
NCT01200693Phase 4

Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

Completed
NCT00697372Phase 4

SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

Completed

All 7 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
7